5.3(top 5%)
impact factor
799(top 20%)
papers
26.5K(top 10%)
citations
67(top 10%)
h-index
5.4(top 5%)
impact factor
880
all documents
29.3K
doc citations
113(top 10%)
g-index

Top Articles

#TitleJournalYearCitations
1Lipid metabolic reprogramming in cancer cellsOncogenesis20161,011
2The hypoxic tumour microenvironmentOncogenesis2018722
3Epigenetic and genetic features of 24 colon cancer cell linesOncogenesis2013658
4Hypoxia and metabolic adaptation of cancer cellsOncogenesis2016572
5Nrf2-Keap1 pathway promotes cell proliferation and diminishes ferroptosisOncogenesis2017422
6Understanding cachexia as a cancer metabolism syndromeOncogenesis2016384
7Glutathione transferases: substrates, inihibitors and pro-drugs in cancer and neurodegenerative diseasesOncogenesis2018373
8Matrix stiffness induces epithelial–mesenchymal transition and promotes chemoresistance in pancreatic cancer cellsOncogenesis2017358
9SOX2 promotes dedifferentiation and imparts stem cell-like features to pancreatic cancer cellsOncogenesis2013275
10Wnt signaling in triple-negative breast cancerOncogenesis2017217
11A mechanism of resistance to gefitinib mediated by cellular reprogramming and the acquisition of an FGF2-FGFR1 autocrine growth loopOncogenesis2013211
12Endoplasmic reticulum stress signaling and chemotherapy resistance in solid cancersOncogenesis2017186
13Hepatic carcinoma-associated fibroblasts induce IDO-producing regulatory dendritic cells through IL-6-mediated STAT3 activationOncogenesis2016178
14Targeting self-renewal pathways in cancer stem cells: clinical implications for cancer therapyOncogenesis2015144
15Urothelial cells undergo epithelial-to-mesenchymal transition after exposure to muscle invasive bladder cancer exosomesOncogenesis2015140
16Enteric bacterial protein AvrA promotes colonic tumorigenesis and activates colonic beta-catenin signaling pathwayOncogenesis2014138
17DeepCC: a novel deep learning-based framework for cancer molecular subtype classificationOncogenesis2019138
18Atlas of Cancer Signalling Network: a systems biology resource for integrative analysis of cancer data with Google MapsOncogenesis2015129
19MUC1 induces drug resistance in pancreatic cancer cells via upregulation of multidrug resistance genesOncogenesis2013128
20Linking genomic reorganization to tumor initiation via the giant cell cycleOncogenesis2016121
21Regulation of the pentose phosphate pathway by an androgen receptor–mTOR-mediated mechanism and its role in prostate cancer cell growthOncogenesis2014116
22A serum-circulating long noncoding RNA signature can discriminate between patients with clear cell renal cell carcinoma and healthy controlsOncogenesis2016107
23The crosstalk between STAT3 and p53/RAS signaling controls cancer cell metastasis and cisplatin resistance via the Slug/MAPK/PI3K/AKT-mediated regulation of EMT and autophagyOncogenesis2019107
24An essential role of Ffar2 (Gpr43) in dietary fibre-mediated promotion of healthy composition of gut microbiota and suppression of intestinal carcinogenesisOncogenesis2016106
25Histone acetyltransferase inhibitors block neuroblastoma cell growth in vivoOncogenesis2015105
26Tumor-derived exosomes induce PD1+ macrophage population in human gastric cancer that promotes disease progressionOncogenesis2018105
27Downregulation of miRNA-31 induces taxane resistance in ovarian cancer cells through increase of receptor tyrosine kinase METOncogenesis2013101
28Identification of LDH-A as a therapeutic target for cancer cell killing via (i) p53/NAD(H)-dependent and (ii) p53-independent pathwaysOncogenesis2014101
29An FBXW7-ZEB2 axis links EMT and tumour microenvironment to promote colorectal cancer stem cells and chemoresistanceOncogenesis201999
30Long non-coding RNA LINC00152 promotes cell proliferation, metastasis, and confers 5-FU resistance in colorectal cancer by inhibiting miR-139-5pOncogenesis201798
31Knockdown of long non-coding RNA XIST increases blood–tumor barrier permeability and inhibits glioma angiogenesis by targeting miR-137Oncogenesis201795
32Inhibition of ATG12-mediated autophagy by miR-214 enhances radiosensitivity in colorectal cancerOncogenesis201895
33NVP-LDE-225 (Erismodegib) inhibits epithelial–mesenchymal transition and human prostate cancer stem cell growth in NOD/SCID IL2Rγ null mice by regulating Bmi-1 and microRNA-128Oncogenesis201392
34MiR-186 inhibited aerobic glycolysis in gastric cancer via HIF-1α regulationOncogenesis201692
35Heparanase-induced shedding of syndecan-1/CD138 in myeloma and endothelial cells activates VEGFR2 and an invasive phenotype: prevention by novel synstatinsOncogenesis201692
36Integrative analyses of transcriptome sequencing identify novel functional lncRNAs in esophageal squamous cell carcinomaOncogenesis201792
37MicroRNA-18a is elevated in prostate cancer and promotes tumorigenesis through suppressing STK4 in vitro and in vivoOncogenesis201491
38Energy disruptors: rising stars in anticancer therapy?Oncogenesis201691
39MAGE-TRIM28 complex promotes the Warburg effect and hepatocellular carcinoma progression by targeting FBP1 for degradationOncogenesis201791
40Deubiquitination of Dishevelled by Usp14 is required for Wnt signalingOncogenesis201390
41Involvement of polypyrimidine tract-binding protein (PTBP1) in maintaining breast cancer cell growth and malignant propertiesOncogenesis201490
42Non-canonical WNT/PCP signalling in cancer: Fzd6 takes centre stageOncogenesis201790
43HOXC8 promotes proliferation and migration through transcriptional up-regulation of TGFβ1 in non-small cell lung cancerOncogenesis201890
44Transglutaminase-2 facilitates extracellular vesicle-mediated establishment of the metastatic nicheOncogenesis202089
45Compensatory angiogenesis and tumor refractorinessOncogenesis201588
46Double agents: genes with both oncogenic and tumor-suppressor functionsOncogenesis201888
47MicroRNA-203 functions as a tumor suppressor in basal cell carcinomaOncogenesis201287
48Hyperglycemia exacerbates colon cancer malignancy through hexosamine biosynthetic pathwayOncogenesis201787
49Deregulation of let-7e in epithelial ovarian cancer promotes the development of resistance to cisplatinOncogenesis201385
50The phosphorylated prodrug FTY720 is a histone deacetylase inhibitor that reactivates ERα expression and enhances hormonal therapy for breast cancerOncogenesis201583